Disease, Disability, and Injury Prevention and Control-Special Emphasis Panel: Center To Protect Worker Rights, Program Announcement (PA) 07-318, 36458 [E7-12837]
Download as PDF
<![CDATA[
36458
Federal Register / Vol. 72, No. 127 / Tuesday, July 3, 2007 / Notices
Eastern time by the deadline listed in
the DATES section at the beginning of
this Notice.
V. Responsiveness Criteria
Each application submitted will be
screened to determine whether it was
received by the closing date and time.
Applications received by the closing
date and time will be screened for
completeness and conformity with the
requirements outlined in Sections III
and IV of this Notice and the Program
Announcement. Only complete
applications that meet these
requirements will be reviewed and
evaluated competitively.
VI. Application Review Information
Eligible applications in response to
this announcement will be reviewed
according to the following evaluation
criteria:
• Purpose and Need for Assistance—
(20 points)
• Approach, Workplan and
Activities—(30 points)
• Outcomes/Evaluation/
Dissemination—(25 points)
• Level of Effort—(25 points).
forth in section 552b(c)(4) and (6), Title 5
U.S.C., and the Determination of the Director,
Management Analysis and Services Office,
CDC, pursuant to Public Law 92–463.
Matters To Be Discussed: The meeting will
include the review, discussion, and
evaluation of research grant applications in
response to PA 07–318, ‘‘Center to Protect
Worker Rights.’’
For Further Information Contact: George
Bockosh, M.S., Designated Federal Officer,
626 Cochran Mill Road, Pittsburgh, PA
15236, telephone 412.386.6465.
The Director, Management Analysis and
Services Office, has been delegated the
authority to sign Federal Register notices
pertaining to announcements of meetings and
other committee management activities, for
both CDC and the Agency for Toxic
Substances and Disease Registry.
Dated: June 27, 2007.
Elaine L. Baker,
Acting Director, Management Analysis and
Services Office, Centers for Disease Control
and Prevention.
[FR Doc. E7–12837 Filed 7–2–07; 8:45 am]
BILLING CODE 4163–18–P
evaluation of individual research grant and
cooperative agreement applications
submitted in response to one Fiscal Year
2007 Request for Applications related to the
following individual research announcement:
RFA–CE–07–011, ‘‘Multi-Level Parent
Training Effectiveness Trial—Phase II (U49).’’
Agenda items are subject to change as
priorities dictate.
Contact Person for More Information: Jane
Suen, NCIPC/ERPO, CDC, 4770 Buford
Highway, NE., M/S K02, Atlanta, Georgia
30341–3724, telephone 770/488–4281, or
Tony Johnson, telephone 770/488–1556.
The Director, Management Analysis
and Services Office has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities for both CDC and
the Agency for Toxic Substances and
Disease Registry.
Dated: June 27, 2007.
Elaine L. Baker,
Acting Director, Management Analysis and
Services Office, Centers for Disease Control
and Prevention.
[FR Doc. E7–12822 Filed 7–2–07; 8:45 am]
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
BILLING CODE 4163–18–P
VII. Agency Contacts
Direct inquiries regarding
programmatic issues to U.S. Department
of Health and Human Services,
Administration on Aging, Office of
Evaluation, Washington, DC 20201,
telephone: (202) 357–0145.
Centers for Disease Control and
Prevention
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Center for Injury Prevention
and Control Initial Review Group
(NCIPC/IRG)
Food and Drug Administration
Dated: June 28, 2007.
Josefina G. Carbonell,
Assistant Secretary for Aging.
[FR Doc. E7–12858 Filed 7–2–07; 8:45 am]
BILLING CODE 4154–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Disease, Disability, and Injury
Prevention and Control—Special
Emphasis Panel: Center To Protect
Worker Rights, Program
Announcement (PA) 07–318
jlentini on PROD1PC65 with NOTICES
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces the following meeting of the
aforementioned committee:
Time and Date: 1 p.m.–2 p.m., July 18,
2007 (Closed).
Place: 626 Cochran Mill Road, Building 20,
Room 313, Pittsburgh, PA 15236.
Status: The meeting will be closed to the
public in accordance with provisions set
VerDate Aug<31>2005
17:57 Jul 02, 2007
Jkt 211001
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces the following meeting of the
aforementioned committee:
Times and Date:
2 p.m.–2:30 p.m., July 31, 2007 (Open).
2:30 p.m.–5 p.m., July 31, 2007 (Closed).
Place: The conference call will originate at
the Centers for Disease Control and
Prevention, Yale Building, Koger Center,
Atlanta, Georgia.
Status: Portions of the meetings will be
closed to the public in accordance with
provisions set forth in Section 552b(c)(4) and
(6), Title 5, U.S.C., and the Determination of
the Director, Management Analysis and
Services Office, CDC, pursuant to Section
10(d) of Public Law 92–463.
Purpose: This group is charged with
providing advice and guidance to the
Secretary, Department of Health and Human
Services, and the Director, CDC, concerning
the scientific and technical merit of grant and
cooperative agreement applications received
from academic institutions and other public
and private profit and nonprofit
organizations, including State and local
government agencies, to conduct specific
injury research that focuses on prevention
and control.
Matters To Be Discussed: The meeting will
include the review, discussion, and
PO 00000
Frm 00040
Fmt 4703
Sfmt 4703
Request for Nominations for Voting
Members on Public Advisory Panels or
Committees
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Notice.
SUMMARY: The Food and Drug
Administration (FDA) is requesting
nominations for voting members to
serve on the Device Good
Manufacturing Practice Advisory
Committee, certain device panels of the
Medical Devices Advisory Committee,
the National Mammography Quality
Assurance Advisory Committee, and the
Technical Electronic Products Radiation
Safety Standards Committee in the
Center for Devices and Radiological
Health. Nominations will be accepted
for current vacancies and those that will
or may occur through August 31, 2008.
FDA has a special interest in ensuring
that women, minority groups, and
individuals with disabilities are
adequately represented on advisory
committees and, therefore, encourages
nominations of qualified candidates
from these groups.
DATES: Because scheduled vacancies
occur on various dates throughout each
year, no cutoff date is established for the
receipt of nominations. However, when
E:\FR\FM\03JYN1.SGM
03JYN1
]]>Agencies
[Federal Register Volume 72, Number 127 (Tuesday, July 3, 2007)]
[Notices]
[Page 36458]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E7-12837]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Disease, Disability, and Injury Prevention and Control--Special
Emphasis Panel: Center To Protect Worker Rights, Program Announcement
(PA) 07-318
In accordance with section 10(a)(2) of the Federal Advisory
Committee Act (Pub. L. 92-463), the Centers for Disease Control and
Prevention (CDC) announces the following meeting of the aforementioned
committee:
Time and Date: 1 p.m.-2 p.m., July 18, 2007 (Closed).
Place: 626 Cochran Mill Road, Building 20, Room 313, Pittsburgh,
PA 15236.
Status: The meeting will be closed to the public in accordance
with provisions set forth in section 552b(c)(4) and (6), Title 5
U.S.C., and the Determination of the Director, Management Analysis
and Services Office, CDC, pursuant to Public Law 92-463.
Matters To Be Discussed: The meeting will include the review,
discussion, and evaluation of research grant applications in
response to PA 07-318, ``Center to Protect Worker Rights.''
For Further Information Contact: George Bockosh, M.S.,
Designated Federal Officer, 626 Cochran Mill Road, Pittsburgh, PA
15236, telephone 412.386.6465.
The Director, Management Analysis and Services Office, has been
delegated the authority to sign Federal Register notices pertaining
to announcements of meetings and other committee management
activities, for both CDC and the Agency for Toxic Substances and
Disease Registry.
Dated: June 27, 2007.
Elaine L. Baker,
Acting Director, Management Analysis and Services Office, Centers for
Disease Control and Prevention.
[FR Doc. E7-12837 Filed 7-2-07; 8:45 am]
BILLING CODE 4163-18-P
